← Back to Search

Single Arm for Lung Disease

N/A
Recruiting
Led By Jun Li, MD
Research Sponsored by Inquis Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to 48 hours
Awards & highlights

Summary

Evaluate the safety and efficacy of the Aventus Thrombectomy System for aspiration thrombectomy in subjects with acute pulmonary embolism.

Eligible Conditions
  • Lung Disease
  • Pulmonary Embolism
  • Respiratory Diseases
  • Cardiovascular Disease
  • Embolism
  • Vascular Disease
  • Blood Clot

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to 48 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to 48 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in RV/LV Ratio
Major Adverse Event Rate

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single ArmExperimental Treatment1 Intervention
Device: Aventus Thrombectomy System
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Thrombectomy
2019
Completed Phase 4
~1000

Find a Location

Who is running the clinical trial?

Inquis Medical, Inc.Lead Sponsor
Jun Li, MDPrincipal InvestigatorUniversity Hospitals
13 Previous Clinical Trials
1,793 Total Patients Enrolled
Saher Sabri, MDPrincipal InvestigatorMedStar Health
~35 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top